Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Inovio Pharmaceuticals Company Profile (NYSE:INO)

Consensus Ratings for Inovio Pharmaceuticals (NYSE:INO) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.20 (104.25% upside)

Analysts' Ratings History for Inovio Pharmaceuticals (NYSE:INO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/24/2014AegisUpgradeHold -> Buy$10.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
6/23/2014AegisInitiated CoveragePositiveViewTweet This Rating  Share This Rating on StockTwits
6/9/2014AegisReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
5/21/2014AegisReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Stifel NicolausInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014Maxim GroupBoost Price TargetBuy$12.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Piper JaffrayBoost Price Target$26.00ViewTweet This Rating  Share This Rating on StockTwits
1/24/2014Brean CapitalBoost Price TargetBuy$12.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013AegisReiterated RatingHold -> Hold$10.00ViewTweet This Rating  Share This Rating on StockTwits
9/12/2013AegisBoost Price TargetHold$6.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
8/16/2013AegisDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/9/2013Maxim GroupBoost Price TargetBuy$4.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013AegisInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2013Maxim GroupInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
1/17/2013Piper JaffrayInitiated CoverageOverweight$4.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/27/2012 forward)